Corvus Pharmaceuticals, Inc. (CRVS) Tops Q3 EPS by 1c
Tweet
Share
E-mail
Get Alerts CRVS Hot Sheet
Join SI Premium – FREE
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) reported Q3 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13).
For earnings history and earnings-related data on Corvus Pharmaceuticals, Inc. (CRVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump Bought At Least $100,001 In Palantir Shares, Disclosure Shows - Bloomberg
- Qatar affirms support for U.S.-Iran talks in key meeting
- Horizon Bancorp faces $3M jury verdict in auto repossession case
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
